<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02150460</url>
  </required_header>
  <id_info>
    <org_study_id>NECKAD/TRIALS/001/2012</org_study_id>
    <nct_id>NCT02150460</nct_id>
  </id_info>
  <brief_title>A Comparison of One-site and Two-site Peribulbar Anaesthesia for Cataract Surgery at Kaduna, Nigeria</brief_title>
  <official_title>A Comparison of One-site and Two-site Peribulbar Anaesthesia for Cataract Surgery at National Eye Centre, Kaduna. Nigeria</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Eye Centre, Kaduna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Eye Centre, Kaduna</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to compare the efficacy and safety of single injection peribulbar
      anaesthesia against the classic double injection technique.

      This was a double blind randomized controlled trial involving two groups of consenting, adult
      Nigerian subjects with operable age-related cataract. An anaesthetic nurse who allocated the
      subjects to the two groups administered all the injections. The same surgeon operated on all
      the subjects while the principal investigator and a research assistant measured the outcome
      variables. All others were blinded as to subject allocation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time Taken to Achieve Adequate Akinesia</measure>
    <time_frame>10 minutes and 15 minutes</time_frame>
    <description>Time taken to achieve akinesia and anesthesia adequate for surgery. Ability to move the eye in each of four directions (up, down, right and left) was scored thus: 2- normal movement, 1- reduced movement and 0- flicker or no movement. Upper eyelid akinesia was scored as 2- normal opening, 1- reduced movement and 0- complete immobility. Maximum score of 10 and minimum of 0. Adequate akinesia was defined as a total score of &lt;4 and was evaluated at 10 and 15 minutes.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Supplementary Injection(s)</measure>
    <time_frame>5 minutes</time_frame>
    <description>After 10 minutes if akinesia score was more than 3, supplementary injections were given and the effect assessed was 5 minutes later</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Complications of Local Anaesthetic Injection</measure>
    <time_frame>0,10 and 15 minutes</time_frame>
    <description>Systemic complications: dyspnoea, bronchospasm, impaired consciousness, intravascular injection etc
Local complications: eyelid oedema, corneal oedema, conjunctival chemosis, conjunctival haemorrhage, globe perforation, vitreous haemorrhage, orbital haemorrhage etc</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Score for Local Anaesthetic Injection</measure>
    <time_frame>20 minutes</time_frame>
    <description>Pain was scored using a 4 point scale: 1 - no pain, 2 - mild pain, 3 - moderate pain, 4 - severe pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Pain Score for Cataract Surgery</measure>
    <time_frame>20 minutes</time_frame>
    <description>Pain was scored on a 4 point scale: 1 - no pain, 2 - mild pain, 3 - moderate pain, 4 - severe pain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Volume of Anaesthetic Drug (ml)</measure>
    <time_frame>10 and 15 minutes</time_frame>
    <description>Total volume of anaesthetic drug injected into the orbit to achieve anaesthesia and akinesia adequate for cataract surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total Number of Injections</measure>
    <time_frame>15 minutes</time_frame>
    <description>Total number of injections required to achieve an akinesia score of &lt;4</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Surgeon Satisfaction Score for Local Anaesthetic Block</measure>
    <time_frame>20 minutes</time_frame>
    <description>Surgeon subjectively scored satisfaction with the anaesthetic block on a 4 point scale: 1- poor (25%), 2 - fair (50%), 3 - good (75%), 4 - excellent (100%)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acceptability of the Anaesthetic Block to the Subject</measure>
    <time_frame>25 minutes</time_frame>
    <description>Subjects were asked if they would agree to have the same anaesthetic procedure the next time they needed cataract surgery in the other eye</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Cataract Surgery (Minutes)</measure>
    <time_frame>At the end of surgery</time_frame>
    <description>Time interval from conjunctival incision to application of eye pad</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">100</enrollment>
  <condition>Anaesthesia</condition>
  <condition>Cataract</condition>
  <arm_group>
    <arm_group_label>One-site peribulbar injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Injection of a mixture of lidocaine 2% + adrenaline 0.125mg/ml + hyaluronidase 15 International Units (IU)/ml into the inferior medial orbital compartment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Two-site peribulbar injection</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Injection of a mixture of lidocaine 2% + adrenaline 0.125mg/ml + hyaluronidase 15IU/ml into the infero-temporal and supero-nasal orbital compartments</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>One-site peribulbar injection</intervention_name>
    <description>injection into the inferior medial orbital compartment</description>
    <arm_group_label>One-site peribulbar injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Two- site peribulbar injection</intervention_name>
    <description>Two injections into the infero-temporal and supero-nasal orbital compartments</description>
    <arm_group_label>Two-site peribulbar injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 50 years and above

          -  Diagnosed with uncomplicated senile cataract

          -  Visual acuity of &lt;3/60

        Exclusion Criteria:

          -  Impaired mental status

          -  Difficulty in speaking

          -  Known allergy to amide-type local anaesthetic agents and/ or hyaluronidase

          -  Previous surgery in the same eye

          -  Glaucoma

          -  Impaired ocular motility

          -  Eyelid abnormalities

          -  Patients with only one eye
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Aminatu A AbdulRahman, MBBS, FWACS</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Eye Centre, Kaduna</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mahmoud B Alhassan, MBBS, FWACS</last_name>
    <role>Study Chair</role>
    <affiliation>National Eye Centre, Kaduna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Eye Centre</name>
      <address>
        <city>Kaduna</city>
        <zip>800001</zip>
        <country>Nigeria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Nigeria</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 26, 2014</study_first_submitted>
  <study_first_submitted_qc>May 26, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 29, 2014</study_first_posted>
  <results_first_submitted>February 13, 2015</results_first_submitted>
  <results_first_submitted_qc>March 15, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">March 17, 2015</results_first_posted>
  <last_update_submitted>March 15, 2015</last_update_submitted>
  <last_update_submitted_qc>March 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 17, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>ophthalmic surgery, peribulbar local anaesthesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cataract</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>One-site Peribulbar Injection</title>
          <description>Injection of a mixture of lidocaine 2% + adrenaline 0.125mg/ml + hyaluronidase 15 International Units (IU)/ml into the inferior medial orbital compartment
One-site peribulbar injection: injection into the inferior medial orbital compartment</description>
        </group>
        <group group_id="P2">
          <title>Two-site Peribulbar Injection</title>
          <description>Injection of a mixture of lidocaine 2% + adrenaline 0.125mg/ml + hyaluronidase 15IU/ml into the infero-temporal and supero-nasal orbital compartments
Two- site peribulbar injection: Two injections into the infero-temporal and supero-nasal orbital compartments</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="50"/>
                <participants group_id="P2" count="50"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>Patients aged 50 years and above with age related operable cataracts that presented for elective cataract surgery during the study period</population>
      <group_list>
        <group group_id="B1">
          <title>One-site Peribulbar Injection</title>
          <description>Injection of a mixture of lidocaine 2% + adrenaline 0.125mg/ml + hyaluronidase 15 International Units (IU)/ml into the inferior medial orbital compartment
One-site peribulbar injection: injection into the inferior medial orbital compartment</description>
        </group>
        <group group_id="B2">
          <title>Two-site Peribulbar Injection</title>
          <description>Injection of a mixture of lidocaine 2% + adrenaline 0.125mg/ml + hyaluronidase 15IU/ml into the infero-temporal and supero-nasal orbital compartments
Two- site peribulbar injection: Two injections into the infero-temporal and supero-nasal orbital compartments</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="50"/>
            <count group_id="B2" value="50"/>
            <count group_id="B3" value="100"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64.30" spread="7.4"/>
                    <measurement group_id="B2" value="62.60" spread="10.7"/>
                    <measurement group_id="B3" value="63.45" spread="9.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21"/>
                    <measurement group_id="B2" value="23"/>
                    <measurement group_id="B3" value="44"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="27"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight (kg)</title>
          <units>kilogram</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="61.48" spread="13.0"/>
                    <measurement group_id="B2" value="57.38" spread="10.3"/>
                    <measurement group_id="B3" value="59.26" spread="11.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time Taken to Achieve Adequate Akinesia</title>
        <description>Time taken to achieve akinesia and anesthesia adequate for surgery. Ability to move the eye in each of four directions (up, down, right and left) was scored thus: 2- normal movement, 1- reduced movement and 0- flicker or no movement. Upper eyelid akinesia was scored as 2- normal opening, 1- reduced movement and 0- complete immobility. Maximum score of 10 and minimum of 0. Adequate akinesia was defined as a total score of &lt;4 and was evaluated at 10 and 15 minutes.</description>
        <time_frame>10 minutes and 15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>One-site peribulbar injection</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Two-site peribulbar injection</description>
          </group>
        </group_list>
        <measure>
          <title>Time Taken to Achieve Adequate Akinesia</title>
          <description>Time taken to achieve akinesia and anesthesia adequate for surgery. Ability to move the eye in each of four directions (up, down, right and left) was scored thus: 2- normal movement, 1- reduced movement and 0- flicker or no movement. Upper eyelid akinesia was scored as 2- normal opening, 1- reduced movement and 0- complete immobility. Maximum score of 10 and minimum of 0. Adequate akinesia was defined as a total score of &lt;4 and was evaluated at 10 and 15 minutes.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>10 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="41"/>
                    <measurement group_id="O2" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>15 minutes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Supplementary Injection(s)</title>
        <description>After 10 minutes if akinesia score was more than 3, supplementary injections were given and the effect assessed was 5 minutes later</description>
        <time_frame>5 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>One-site peribulbar injection</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Two-site peribulbar injection</description>
          </group>
        </group_list>
        <measure>
          <title>Supplementary Injection(s)</title>
          <description>After 10 minutes if akinesia score was more than 3, supplementary injections were given and the effect assessed was 5 minutes later</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Complications of Local Anaesthetic Injection</title>
        <description>Systemic complications: dyspnoea, bronchospasm, impaired consciousness, intravascular injection etc
Local complications: eyelid oedema, corneal oedema, conjunctival chemosis, conjunctival haemorrhage, globe perforation, vitreous haemorrhage, orbital haemorrhage etc</description>
        <time_frame>0,10 and 15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>One-site peribulbar injection</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Two-site peribulbar injection</description>
          </group>
        </group_list>
        <measure>
          <title>Complications of Local Anaesthetic Injection</title>
          <description>Systemic complications: dyspnoea, bronchospasm, impaired consciousness, intravascular injection etc
Local complications: eyelid oedema, corneal oedema, conjunctival chemosis, conjunctival haemorrhage, globe perforation, vitreous haemorrhage, orbital haemorrhage etc</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Deviation of the globe</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sunconjunctival haemorrhage</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Chemosis</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Score for Local Anaesthetic Injection</title>
        <description>Pain was scored using a 4 point scale: 1 - no pain, 2 - mild pain, 3 - moderate pain, 4 - severe pain</description>
        <time_frame>20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>One-site peribulbar injection</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Two-site peribulbar injection</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score for Local Anaesthetic Injection</title>
          <description>Pain was scored using a 4 point scale: 1 - no pain, 2 - mild pain, 3 - moderate pain, 4 - severe pain</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.64" spread="0.6"/>
                    <measurement group_id="O2" value="1.58" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Volume of Anaesthetic Drug (ml)</title>
        <description>Total volume of anaesthetic drug injected into the orbit to achieve anaesthesia and akinesia adequate for cataract surgery</description>
        <time_frame>10 and 15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>One-site peribulbar injection</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Two-site peribulbar injection</description>
          </group>
        </group_list>
        <measure>
          <title>Volume of Anaesthetic Drug (ml)</title>
          <description>Total volume of anaesthetic drug injected into the orbit to achieve anaesthesia and akinesia adequate for cataract surgery</description>
          <units>milliliters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5.36" spread="0.78"/>
                    <measurement group_id="O2" value="5.40" spread="0.88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Total Number of Injections</title>
        <description>Total number of injections required to achieve an akinesia score of &lt;4</description>
        <time_frame>15 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>One-site peribulbar injection</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Two-site peribulbar injection</description>
          </group>
        </group_list>
        <measure>
          <title>Total Number of Injections</title>
          <description>Total number of injections required to achieve an akinesia score of &lt;4</description>
          <units>injections</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.18" spread="0.39"/>
                    <measurement group_id="O2" value="2.18" spread="0.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Surgeon Satisfaction Score for Local Anaesthetic Block</title>
        <description>Surgeon subjectively scored satisfaction with the anaesthetic block on a 4 point scale: 1- poor (25%), 2 - fair (50%), 3 - good (75%), 4 - excellent (100%)</description>
        <time_frame>20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>One-site peribulbar injection</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Two-site peribulbar injection</description>
          </group>
        </group_list>
        <measure>
          <title>Surgeon Satisfaction Score for Local Anaesthetic Block</title>
          <description>Surgeon subjectively scored satisfaction with the anaesthetic block on a 4 point scale: 1- poor (25%), 2 - fair (50%), 3 - good (75%), 4 - excellent (100%)</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="1" upper_limit="4"/>
                    <measurement group_id="O2" value="4" lower_limit="1" upper_limit="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Acceptability of the Anaesthetic Block to the Subject</title>
        <description>Subjects were asked if they would agree to have the same anaesthetic procedure the next time they needed cataract surgery in the other eye</description>
        <time_frame>25 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>One-site peribulbar injection</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Two-site peribulbar injection</description>
          </group>
        </group_list>
        <measure>
          <title>Acceptability of the Anaesthetic Block to the Subject</title>
          <description>Subjects were asked if they would agree to have the same anaesthetic procedure the next time they needed cataract surgery in the other eye</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="50"/>
                    <measurement group_id="O2" value="50"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Cataract Surgery (Minutes)</title>
        <description>Time interval from conjunctival incision to application of eye pad</description>
        <time_frame>At the end of surgery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>One-site peribulbar injection</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Two-site peribulbar injection</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Cataract Surgery (Minutes)</title>
          <description>Time interval from conjunctival incision to application of eye pad</description>
          <units>minutes</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.78" spread="2.19"/>
                    <measurement group_id="O2" value="8.88" spread="2.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Pain Score for Cataract Surgery</title>
        <description>Pain was scored on a 4 point scale: 1 - no pain, 2 - mild pain, 3 - moderate pain, 4 - severe pain</description>
        <time_frame>20 minutes</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Group 1</title>
            <description>One-site peribulbar injection</description>
          </group>
          <group group_id="O2">
            <title>Group 2</title>
            <description>Two-site peribulbar injection</description>
          </group>
        </group_list>
        <measure>
          <title>Pain Score for Cataract Surgery</title>
          <description>Pain was scored on a 4 point scale: 1 - no pain, 2 - mild pain, 3 - moderate pain, 4 - severe pain</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="50"/>
                <count group_id="O2" value="50"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.06" spread="0.2"/>
                    <measurement group_id="O2" value="1.06" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>3 months</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Group 1</title>
          <description>One-site peribulbar injection</description>
        </group>
        <group group_id="E2">
          <title>Group 2</title>
          <description>Two-site peribulbar injection</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" subjects_affected="14" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Chemosis</sub_title>
                <description>Swelling of the conjunctiva</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="50"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="50"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Aminatu Ali AbdulRahman</name_or_title>
      <organization>National Eye Centre, Kaduna. Nigeria</organization>
      <phone>+2348037878367</phone>
      <email>aaaminatu@yahoo.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

